Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Precision BioSciences, Inc. (DTIL) had Free Cash Flow of $-54.64M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.01M |
|
$-21.77M |
|
-- |
|
$0.01M |
|
$20.68M |
|
$-20.67M |
|
$-1.10M |
|
$-21.77M |
|
$-21.77M |
|
$-21.77M |
|
$-21.77M |
|
$-21.77M |
|
$-21.77M |
|
$-20.67M |
|
$-20.22M |
|
11.82M |
|
11.82M |
|
$-1.84 |
|
$-1.84 |
|
| Balance Sheet Financials | |
$51.70M |
|
$2.03M |
|
$41.80M |
|
$93.51M |
|
$15.00M |
|
$22.37M |
|
$61.88M |
|
$76.88M |
|
$16.63M |
|
$15.65M |
|
$16.63M |
|
12.08M |
|
| Cash Flow Statement Financials | |
$-54.59M |
|
$-0.31M |
|
$17.65M |
|
$108.47M |
|
$71.21M |
|
$-37.26M |
|
$8.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.45 |
|
-- |
|
-- |
|
0.57 |
|
1.35 |
|
100.00% |
|
-158976.90% |
|
-158976.90% |
|
-- |
|
-167476.90% |
|
-167476.90% |
|
|
Free Cash Flow |
$-54.64M |
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
3.25 |
|
27.69 |
|
-130.89% |
|
-139.13% |
|
-23.28% |
|
-55.81% |
|
$1.38 |
|
$-4.62 |
|
$-4.62 |
|